| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023975 |
| Receipt No. | R000027540 |
| Official scientific title of the study | Effect of Non-essential Amino Acids on Protein Requirements for Endurance Athletes Using Indicator Amino Acid Oxidation Method |
| Date of disclosure of the study information | 2016/09/12 |
| Last modified on | 2017/09/05 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Effect of Non-essential Amino Acids on Protein Requirements for Endurance Athletes Using Indicator Amino Acid Oxidation Method | |
| Title of the study (Brief title) | Effect of Non-essential Amino Acids on Protein Requirements | |
| Region |
|
|
| Condition | ||
| Condition | Healthy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The objective of the current study is to investigate the importance of Non Essential Amino Acids for endurance-trained male subjects |
| Basic objectives2 | Others |
| Basic objectives -Others | The objective of the current study is to investigate the importance of Non Essential Amino Acids for endurance-trained male subjects |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 13CO2 (carbon dioxide) excretion rate |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | BASE egg protein
0.8 g/kg/d of protein provided as crystalline amino acid modeled after egg protein |
|
| Interventions/Control_2 | BCAA-enriched egg protein
BCAA-enriched egg protein provided as crystalline amino acid. |
|
| Interventions/Control_3 | small amount of essential amino acids
essential amino acids modeled after egg protein, provided as crystalline amino acid, which is equivalent to the amount of essential amino acid in BASE egg protein |
|
| Interventions/Control_4 | large amount of essential amino acids
essential amino acids modeled after egg protein, provided as crystalline amino acid, which is equivalent to the amount of amino acid in BCAA-enriched egg protein |
|
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | -endurance-trained participants who regularly run more than 40 km/week.
-Ability to complete the 16-km familiarization run. |
|||
| Key exclusion criteria | -Inability to meet health and physical activity guidelines according to the physical activity readiness questionnaire (PAR-Q+)
-Inability to adhere to any of the protocol guidelines (i.e. alcohol, caffeine consumption) -Regular tobacco use -Illicit drug use |
|||
| Target sample size | 8 | |||
| Research contact person | |
| Name of lead principal investigator | Daniel Moore |
| Organization | University of Toronto |
| Division name | Faculty of kinesiology and physical education |
| Address | 100 Devonshire Place, Toronto, Ontario |
| TEL | +1-416-946-4088 |
| dr.moore@utoronto.ca | |
| Public contact | |
| Name of contact person | Hiroyuki KATO |
| Organization | University of Toronto |
| Division name | Faculty of Kinesiology and physical education |
| Address | 100 Devonshire Place, Toronto, Ontario |
| TEL | +1-416-946-5620 |
| Homepage URL | |
| h.kato@utoronto.ca | |
| Sponsor | |
| Institute | University of Toronto |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ajinomoto co. Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | NCT02874638 |
| Org. issuing International ID_1 | clinicaltrial.gov |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027540 |